Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron

Biomed Pharmacother. 2021 Jan:133:110995. doi: 10.1016/j.biopha.2020.110995. Epub 2020 Nov 21.

Abstract

Chronic stress and high levels of glucocorticoids produce functional and structural changes in brain and especially in the hippocampus, an important limbic system structure that plays a key role in cognitive functions including learning and memory. Alzheimer's disease (AD) is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Indeed, cognitive dysfunction, neuronal atrophy, and synaptic loss are associated with both AD and chronic stress. Recent preclinical and clinical studies have highlighted a possible link between chronic stress, cognitive decline and the development of AD. It is suggested that Tau protein is an essential mediator of the neurodegenerative effects of stress and glucocorticoids towards the development of AD pathology. Recent findings from animal and humans studies demonstrated that saffron and its main constitutive crocin are effective against chronic stress-induced cognitive dysfunction and oxidative stress and slowed cognitive decline in AD. The inhibitory actions on acetylcholinesterase activity, aggregation of beta-amyloid protein into amyloid plaques and tau protein into neurofibrillary tangles, and also the antioxidant, anti-inflammatory, and the promotion of synaptic plasticity effects are among the possible mechanisms to explain the neuroprotective effects of saffron. New evidences demonstrate that saffron and its main component crocin might be a promising target for cognition improvement in AD and stress-related disorders.

Keywords: Alzheimer’s disease; Chronic stress; Cognitive dysfunction; Saffron.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / psychology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Carotenoids / isolation & purification
  • Carotenoids / therapeutic use*
  • Cholinesterase Inhibitors / therapeutic use
  • Chronic Disease
  • Cognition / drug effects*
  • Crocus* / chemistry
  • Humans
  • Inflammation / complications
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Nootropic Agents / isolation & purification
  • Nootropic Agents / therapeutic use*
  • Oxidative Stress / drug effects
  • Phosphorylation
  • Risk Factors
  • Stress, Psychological / complications
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / metabolism
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents
  • Antioxidants
  • Cholinesterase Inhibitors
  • Nootropic Agents
  • tau Proteins
  • Carotenoids
  • crocin